Scientists at The University of Nottingham have developed a new substance which could simplify the manufacture of cell therapy in the pioneering world of regenerative medicine.
Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have the potential to repair human tissue and maintain organ function in chronic disease and age-related illnesses. But a major problem with translating current successful research into actual products and treatments is how to mass-produce such a complex living material.
There are two distinct phases in the production of stem cell products; proliferation (making enough cells to form large tissue) and differentiation (turning the basic stem cells into functional cells). The material environment required for these two phases are different and up to now a single substance that does both jobs has not been available.
Now a multi-disciplinary team of researchers at Nottingham has created a new stem cell micro-environment which they have found has allowed both the self-renewal of cells and then their evolution into cardiomyocyte (heart) cells. The material is a hydrogel containing two polymers – an alginate-rich environment which allows proliferation of cells with a simple chemical switch to render the environment collagen-rich when the cell population is large enough. This change triggers the next stage of cell growth when cells develop a specific purpose.
Professor of Advanced Drug Delivery and Tissue Engineering, Kevin Shakesheff, said:
“Our new combination of hydrogels is a first. It allows dense tissue structures to be produced from human pluripotent stem cells (HPSC) in a single step process never achieved before. The discovery has important implications for the future of manufacturing in regenerative medicine. This field of healthcare is a major priority for the UK and we are seeing increasing investment in future manufacturing processes to ensure we are ready to deliver real treatments to patients when HPSC products and treatments go to trial and become standard.”
The Latest on: Stem cell manufacturing
via Google News
The Latest on: MStem cell manufacturing
- CNS Pharmaceuticals Announces Completion of GMP Manufacturingon February 4, 2020 at 4:00 am
/PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel ...
- Mesenchymal Stem Cells Market Size and Revenue Projection To 2029 || Lonza, Thermo Fisher, Bio-Techneon February 4, 2020 at 2:56 am
Mesenchymal Stem Cells Market Moving 2020 Towards With New Procedures, Provides Exhaustive PEST Analysis by 2029 An executive summary created through considerable unique primary research (inputs from ...
- AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington'son February 3, 2020 at 6:22 am
including industrial scalable manufacturing, lower cost of goods, and clonal cells with high purity and identity. Our goal is to have an improved neural stem cell production method ready within a year ...
- Mechanobiology Analysis of Manifold Live Cells in Vitro with Atomic Force Acoustic Microscopyon January 30, 2020 at 8:43 pm
Ministry of Education Key Laboratory for Cross-Scale Micro and Nano Manufacturing, Changchun University of Science ... important parameters to explore the physiological behavior inside cells. However, ...
- Hydrogen Fuel Cells And The Zero-Emission Supply Chain Of Tomorrowon January 30, 2020 at 4:17 am
Once the hydrogen and fuel cell technology ecosystem is fully mature, it could have the potential to transform each link in the global supply chain.
- Cancer Stem Cells Market Expected to Generate Revenue of $ 1,722.7 Million, Growing at a CAGR of 10.3% by 2026on January 30, 2020 at 4:00 am
/PRNewswire/ -- According to Research Dive, Global Cancer Stem Cells Market will reach upto $1,722.7 million by the end of year 2026. Increasing number ...
- Column: U.S. judge rejects FDA bid to shut down stem cell clinics, dealing blow to regulatorson January 29, 2020 at 3:09 pm
The FDA also asserted in its lawsuit that the defendants had not instituted safeguards in its manufacturing processes to “prevent microbial contamination” of their products. The California defendants ...
- Solar Cells Market by 2024| Global Growth Drivers and Geographic Analysison January 29, 2020 at 2:20 am
Global solar cells market is anticipated to witness considerable expansion in the forthcoming years owing to increasing measures undertaken by governments and other regulatory authorities to promote ...
- Controlled clustering enhances PDX1 and NKX6.1 expression in pancreatic endoderm cells derived from pluripotent stem cellson January 27, 2020 at 2:14 am
and more reproducible manufacturing route to drive morphogenesis and produce well-differentiated pancreatic cell clusters. In this work, we propose that culture in adhesive micropatterns can be ...
- Snake stem cells used to create venom-producing organoidson January 23, 2020 at 8:17 am
Yet the methods for manufacturing antivenom haven't changed since the 19th century," says senior author Hans Clevers of the Hubrecht Institute for Developmental Biology and Stem Cell Research at ...
via Bing News